Neurodevelopment among children under five years with sickle cell disease in Eastern Uganda: A propensity score analysis
AIM: We compared neurodevelopment among children under-five years with and without sickle cell disease in eastern Uganda. METHODS: We conducted a cross-sectional study between March and September 2025 at the pediatric sickle cell clinic of Mbale Regional Referral Hospital. We included 350 children under five years (117 with sickle cell disease and 233 without sickle cell disease). The primary outcome was neurodevelopment assessed using the Malawi Development Assessment Tool. We performed independent sample t-tests to compare development for age z-scores between children with and without sickle cell disease. We used inverse probability of treatment weighting analyses to calculate the effect of sickle cell disease on neurodevelopment. RESULTS: The median age of the children was 40.9 months (interquartile range 27.8 to 54.3 months). Children with sickle cell disease had 0.89 lower DAZ scores compared to their peers without sickle cell disease. Among the children with sickle cell disease, those not enrolled on hydroxyurea had 0.4 lower DAZ scores in the social and language domains compared to those on hydroxyurea. The average exposure effect, obtained from the inverse probability of treatment weighting analyses, was -0.87, 95% CI [-1.19, -0.55] and the average exposure effect among the exposed was - 0.62 95% CI [- 1.01, - 0.23]. CONCLUSION: Children with sickle cell disease had lower developmental scores across all domains (social, gross motor, fine motor and language) compared to community controls. These findings highlight the developmental vulnerability associated with sickle cell disease in early childhood. Efforts towards timely screening and management of developmental delays among children are needed to improve their quality of life and long-term development. This may be through integration of neurodevelopmental screening into routine sickle cell disease care.
Authors
- Peter Olupot‐Olupot (ORCID: https://orcid.org/0000-0002-5757-609X)
- Sarah Kiguli (ORCID: https://orcid.org/0000-0002-8764-4161)
- Lawrence Ssegawa
- Sarah Mutonyi (ORCID: https://orcid.org/0000-0002-0010-3726)
- Milton Wamboko Musaba (ORCID: https://orcid.org/0000-0003-4145-4044)
- Brendah Nambozo (ORCID: https://orcid.org/0009-0002-8600-8654)
- David Mukunya (ORCID: https://orcid.org/0000-0002-3892-9777)
- Julian Abeso
- Deogratias Munube (ORCID: https://orcid.org/0000-0002-1312-6804)
- Faith Oguttu (ORCID: https://orcid.org/0009-0006-7481-3321)
- Joel Okwir
- Henry K Nabudere
- Bernard Maumbe
- Susan Lunyolo
Institutions
- Mbale Hospital (UG)
- Busitema University (UG)
- Makerere University (UG)
Publication Details
- Journal
- PLoS ONE
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1371/journal.pone.0363134
- Primary Topic
- Hemoglobinopathies and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- Fogarty International Center